Navigation Links
OICR Makes Equity Investment in Medical Information Company
Date:10/12/2010

TORONTO, Oct. 12 /PRNewswire/ -- The Ontario Institute for Cancer Research (OICR) today announced it has made an equity investment in Privacy Analytics Inc., an Ontario company that is developing a software platform to help organizations such as health centers disclose detailed disease and treatment data without compromising individual privacy.

The software platform, called Privacy Analytics Risk Assessment Tool (PARAT), is currently being used by hospitals and patient registries in Canada. The funding from OICR will be used to extend the functionality of PARAT to include more powerful capabilities.

"With the increasing volumes of personal health data being collected today, there are rising demands to use that data for multiple purposes, including trend detection, public health monitoring of diseases such as cancer, and predictive modeling," said Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of OICR. "However, the breach of personal information can often result in costly legislative action, litigation and reputational damage, all of which can cripple an organization.  PARAT protects individual privacy while unlocking the potential of vast amounts of data on diseases and patient care."

"The current approaches for dealing with privacy in medical data result in excessive distortion of the information," said Dr. Khaled El Emam, from the University of Ottawa, who is serving as the lead investigator for OICR for the application of PARAT technology. "The PARAT software will address this shortcoming, permitting more sophisticated and accurate analyses of health data for multiple purposes while protecting patient identity."

PARAT is a Windows based application and is compatible with a number of databases (Oracle, Microsoft SQL Server). Using a simple four-step process, PARAT allows for easy and safe disclosure of data. The funding from OICR will also be used to support the marketing and sales of the improved PARAT software into new markets.

Funding from OICR is provided through its Intellectual Property Development and Commercialization Program, which provides seed funding for late stage academic projects that meet specific market-oriented criteria. The PARAT technology was chosen for funding in part because it advances OICR's commitment to the prevention, early detection, diagnosis and treatment of cancer.

About OICR

OICR, based in Ontario, Canada, is a new, innovative cancer research & development institute dedicated to prevention, early detection, diagnosis and treatment of cancer. The Institute is an independent, not-for-profit corporation funded by the Government of Ontario through the Ministry of Research and Innovation. OICR has 300 scientific staff (located at its headquarters and in research institutes and academia across the Province of Ontario) and an $85 million annual operating budget. It has key research efforts underway in small molecules, biologics, stem cells, imaging, genomics, informatics and bio-computing, from early stage research to Phase I clinical trials.

For more information, please visit the website at www.oicr.on.ca/commercialization.


'/>"/>
SOURCE The Ontario Institute for Cancer Research
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SciQuest Makes the Inc. 500
2. 5000 List of Fastest-Growing Companies for Fourth Consecutive Year
3. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
4. New method makes vaccines stable at tropical temperatures
5. Ethanol Blend Reduction in Brazil Makes Sense Provided 90-Day Deadline is Respected, Says Brazilian Sugarcane Industry Association
6. Woman Owned Business President Makes Her Mark at Professional Reprographics
7. U of A led team makes breakthrough demonstration of pH-regulating protein
8. Bioheart Makes Breakthrough in Critical Limb Ischemia Therapy with Stem Cells Obtained from Fat Tissue
9. Promega HaloTag Protein Purification System Makes it Easier to Purify Difficult-to-Express Proteins
10. FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKlines Candidate Cervical Cancer Vaccine
11. Biomatrica Makes Several Key Appointments as Part of Continued Growth Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... ... The leading Regenerative Veterinary Medicine Company, VetStem Biopharma ., is proud ... of their own patients with the VetStem Cell Therapy. Each of these veterinarians has ... patients. , The veterinarians are Dr Ross Rich former owner of Cave Creek ...
(Date:5/19/2016)... ... ... Anton Paar USA, located in Ashland, Virginia is pleased to announce that construction ... a third office building to the current facilities. , Growth is nothing new. ... with office space adjacent to the previous main building. Through remodels and new construction, ...
(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... , May 18, 2016 The Biotech ... does not mean that there are no opportunities ahead. Today, ... Inc. (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... ), and Ophthotech Corp. (NASDAQ: OPHT ). Sign ... at: http://www.activewallst.com/ Threshold Pharmaceuticals ...
Breaking Biology Technology:
(Date:5/9/2016)... -- Elevay is currently known as the ... high net worth professionals seeking travel for work   ... there is still no substitute for a face-to-face meeting. ... deal with a firm handshake. This is why wealthy ... citizenship via investment programs like those offered by the ...
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
Breaking Biology News(10 mins):